Condensed Consolidated Interim Statements of Stockholders Equity - USD ($) $ in Thousands	Common Stock Common Class A	Common Stock Common Class B	Additional Paid-in Capital	Accumulated Deficit Cumulative impact of adopting ASU 2016-13	Accumulated Deficit	Accumulated Other Comprehensive Loss	Noncontrolling Interest Cumulative impact of adopting ASU 2016-13	Noncontrolling Interest	Cumulative impact of adopting ASU 2016-13	Total
Balance at Beginning of period at Dec. 31, 2021	$ 66	$ 47	$ 226,717		$ (171,209)	$ (325)		$ 42,145		$ 97,441
Balance at Beginning of period (in shares) at Dec. 31, 2021	65,583,289	47,470,971
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)					(7,265)			(5,259)		(12,524)
Stock-based compensation			6,890					4,987		11,877
Foreign currency translation						(50)		(36)		(86)
Balance at end of period (in shares) at Mar. 31, 2022	65,583,289	47,470,971
Balance at end of period at Mar. 31, 2022	$ 66	$ 47	233,607		(178,474)	(375)		41,837		96,708
Balance at Beginning of period at Dec. 31, 2022	$ 71	$ 43	244,260	$ (94)	(178,863)	(504)	$ (55)	38,437	$ (149)	103,444
Balance at Beginning of period (in shares) at Dec. 31, 2022	70,859,711	43,198,767
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)					2,945			1,749		4,694
Stock-based compensation			(640)					(398)		(1,038)
Share exchange	$ 2	$ (2)	1,376					(1,376)
Share exchange (in shares)	2,000,000	(2,000,000)
Issuance of IPO vested Class A common stock and share-based awards	$ 1		(1)
Issuance of IPO vested Class A common stock and share-based awards (in shares)	1,221,912
Tax withholdings related to net share settlements of stock-based compensation awards			(4,739)					(2,840)		(7,579)
Foreign currency translation						31		17		48
Other			(181)					(94)		(275)
Balance at end of period (in shares) at Mar. 31, 2023	74,081,623	41,198,767
Balance at end of period at Mar. 31, 2023	$ 74	$ 41	$ 240,075		$ (176,012)	$ (473)		$ 35,440		$ 99,145